BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33535527)

  • 1. Advances and Obstacles in Homology-Mediated Gene Editing of Hematopoietic Stem Cells.
    Salisbury-Ruf CT; Larochelle A
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates.
    Romero Z; Lomova A; Said S; Miggelbrink A; Kuo CY; Campo-Fernandez B; Hoban MD; Masiuk KE; Clark DN; Long J; Sanchez JM; Velez M; Miyahira E; Zhang R; Brown D; Wang X; Kurmangaliyev YZ; Hollis RP; Kohn DB
    Mol Ther; 2019 Aug; 27(8):1389-1406. PubMed ID: 31178391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
    Gundry MC; Brunetti L; Lin A; Mayle AE; Kitano A; Wagner D; Hsu JI; Hoegenauer KA; Rooney CM; Goodell MA; Nakada D
    Cell Rep; 2016 Oct; 17(5):1453-1461. PubMed ID: 27783956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders.
    Allen D; Kalter N; Rosenberg M; Hendel A
    Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders.
    Buffa V; Alvarez Vargas JR; Galy A; Spinozzi S; Rocca CJ
    Front Genome Ed; 2022; 4():997142. PubMed ID: 36698790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 challenge of hematopoietic stem cell gene editing.
    Dorset SR; Bak RO
    Mol Ther Methods Clin Dev; 2023 Sep; 30():83-89. PubMed ID: 37435043
    [No Abstract]   [Full Text] [Related]  

  • 7. An improved medium formulation for efficient
    Rai R; Naseem A; Vetharoy W; Steinberg Z; Thrasher AJ; Santilli G; Cavazza A
    Mol Ther Methods Clin Dev; 2023 Jun; 29():58-69. PubMed ID: 36950452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation.
    Ferrari S; Vavassori V; Canarutto D; Jacob A; Castiello MC; Javed AO; Genovese P
    Front Genome Ed; 2021; 3():618378. PubMed ID: 34713250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplex HDR for disease and correction modeling of SCID by CRISPR genome editing in human HSPCs.
    Iancu O; Allen D; Knop O; Zehavi Y; Breier D; Arbiv A; Lev A; Lee YN; Beider K; Nagler A; Somech R; Hendel A
    Mol Ther Nucleic Acids; 2023 Mar; 31():105-121. PubMed ID: 36618262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune System.
    Porteus MH; Pavel-Dinu M; Pai SY
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):647-665. PubMed ID: 35773054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1.
    Schiroli G; Ferrari S; Conway A; Jacob A; Capo V; Albano L; Plati T; Castiello MC; Sanvito F; Gennery AR; Bovolenta C; Palchaudhuri R; Scadden DT; Holmes MC; Villa A; Sitia G; Lombardo A; Genovese P; Naldini L
    Sci Transl Med; 2017 Oct; 9(411):. PubMed ID: 29021165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells.
    Ferrari S; Jacob A; Cesana D; Laugel M; Beretta S; Varesi A; Unali G; Conti A; Canarutto D; Albano L; Calabria A; Vavassori V; Cipriani C; Castiello MC; Esposito S; Brombin C; Cugnata F; Adjali O; Ayuso E; Merelli I; Villa A; Di Micco R; Kajaste-Rudnitski A; Montini E; Penaud-Budloo M; Naldini L
    Cell Stem Cell; 2022 Oct; 29(10):1428-1444.e9. PubMed ID: 36206730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response.
    Schiroli G; Conti A; Ferrari S; Della Volpe L; Jacob A; Albano L; Beretta S; Calabria A; Vavassori V; Gasparini P; Salataj E; Ndiaye-Lobry D; Brombin C; Chaumeil J; Montini E; Merelli I; Genovese P; Naldini L; Di Micco R
    Cell Stem Cell; 2019 Apr; 24(4):551-565.e8. PubMed ID: 30905619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles.
    Yu KR; Natanson H; Dunbar CE
    Hum Gene Ther; 2016 Oct; 27(10):729-740. PubMed ID: 27483988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.
    Wang J; Exline CM; DeClercq JJ; Llewellyn GN; Hayward SB; Li PW; Shivak DA; Surosky RT; Gregory PD; Holmes MC; Cannon PM
    Nat Biotechnol; 2015 Dec; 33(12):1256-1263. PubMed ID: 26551060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing CRISPR Efficiency and Measuring Its Specificity in HSPCs Using a Clinically Relevant System.
    Shapiro J; Iancu O; Jacobi AM; McNeill MS; Turk R; Rettig GR; Amit I; Tovin-Recht A; Yakhini Z; Behlke MA; Hendel A
    Mol Ther Methods Clin Dev; 2020 Jun; 17():1097-1107. PubMed ID: 32478125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting.
    Charlesworth CT; Camarena J; Cromer MK; Vaidyanathan S; Bak RO; Carte JM; Potter J; Dever DP; Porteus MH
    Mol Ther Nucleic Acids; 2018 Sep; 12():89-104. PubMed ID: 30195800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular RNase activity dampens zinc finger nuclease-mediated gene editing in hematopoietic stem and progenitor cells.
    Peterson CW; Venkataraman R; Reddy SS; Pande D; Enstrom MR; Radtke S; Humbert O; Kiem HP
    Mol Ther Methods Clin Dev; 2022 Mar; 24():30-39. PubMed ID: 34977270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing.
    Ling C; Bhukhai K; Yin Z; Tan M; Yoder MC; Leboulch P; Payen E; Srivastava A
    Sci Rep; 2016 Oct; 6():35495. PubMed ID: 27759036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prime editing in hematopoietic stem cells-From
    Wolff JH; Mikkelsen JG
    Front Genome Ed; 2023; 5():1148650. PubMed ID: 36969373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.